养老院居民SARS-CoV-2疫苗抗体应答支持半年加强接种方案
该回顾性观察队列研究分析了697名养老院居民和127名医护人员接种疫苗后最长400天的血清抗体水平,发现养老院居民的中和与结合抗体滴度从接种后2周至12个月显著下降,既往感染者的抗体峰值更高且衰减更慢,免疫学数据支持CDC对65岁以上人群半年加强接种的建议。
要点
- 养老院居民接种后2周至12个月抗体滴度显著下降
- 既往感染者抗体峰值更高且衰减更慢
- 免疫学发现支持65岁以上人群半年加强接种
核心结论
- 养老院居民的免疫学发现与现有老年人真实世界临床有效性数据一致,支持CDC关于半年接种以降低65岁及以上人群重症COVID-19结局的建议。
研究设计与样本
- 观察性回顾性队列研究,分析来自俄亥俄州东北部和罗德岛697名养老院居民和127名医护人员的接种后血清样本,随访长达400天。
主要发现
- 养老院居民的武汉株和Omicron BA.4/5中和及结合抗体滴度从接种后2周至12个月显著下降。
- 既往感染SARS-CoV-2的养老院居民比未感染者具有更高的抗体峰值滴度和更慢的衰减速度。
- 未感染养老院居民接种后抗体水平落后于医护人员和既往感染养老院居民,但随后以相似速率衰减。
临床怎么用
- 免疫学证据支持对65岁及以上人群按CDC建议实施半年加强接种,以降低重症COVID-19风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The COVID-19 pandemic has greatly affected nursing home residents (NHRs), a vulnerable group with high rates of illness and death. While vaccination is essential for reducing infections and severe outcomes in the short term, it is important to understand how long antibody levels and neutralizing activity last. This understanding will help us create effective public health strategies for the long term. According to current CDC guidelines, individuals over 65 should receive a booster dose six months after their previous vaccination. METHODS: This observational retrospective cohort study analyzed post-vaccination serum from samples with up to 400 days of follow-up from 697 NHRs and 127 healthcare workers (HCWs) across Northeast Ohio and Rhode Island. Analyses were conducted to model decay rates of neutralizing and binding antibody titers and the impact of previous exposures to SARS-CoV-2 on these decay rates. RESULTS: Results indicate that NHRs show Wuhan and Omicron BA.4/5 neutralizing and binding antibody titers diminish significantly from 2 weeks to 12 months post-vaccination. NHRs with prior infection show higher peak antibody titers and slower decay than those naive to infection. Antibody levels after vaccination for infection-naive NHR lagged HCW and NHR with prior infection, but then decayed at a similar rate. CONCLUSION: The immunologic findings in this cohort of NHR align with the existing real-world clinical effectiveness data in older individuals and support the CDC recommendation of a bi-annual vaccination to reduce severe COVID-19 outcomes in persons age 65 and older.
引用
- Paxitzis AN, Oyebanji OA, Olagunju OJ, et al. Antibody responses to SARS-CoV-2 vaccine in nursing home residents support a Bi-annual update schedule. Vaccine. 2026. PMID: 41581480. doi:10.1016/j.vaccine.2026.128240
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。